Methods: Forty-one patients with breast cancer were enrolled in the study and given Rujifang with chemotherapy.The hematological toxicities,tumor marks and cellular immunologic function were compared.

• 方法:41例乳腺癌患者均给予至少一周期化学治疗,在化疗期间配合以乳积方为基础方的中药治疗,通过自身前后对照,观察治疗前和治疗两周后血液学、肿瘤标志物和细胞免疫等指标的变化。